Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Swartz is still selling.

RE: Swartz is still selling.

posted on Jun 28, 2006 10:12AM
That would make sense if we`re in the process of reducing float - they would have to sell in order to stay under their holding limits.

(changing gears here)

I`m estatic over today`s Pentax news. Pohl commented on 6 more signings before year end (anyone able to clarify if thats FY or calendar?)...regardless, we`ve seen 4 in the span of 1 month.

Notwithstanding on the Revs issue, the overall TPL research, licensee/licensor working relationship and signing strategy is working well. A well thought out plan so far, with results.

This reinforces my belief that we should just other aspects of the TPL/PTSC strategy to play out - let business and information release control (read - no revs. posted) remain just as it is, stop complaining and move on to more productive topics.

Regards

Share
New Message
Please login to post a reply